MiMedx Current Ratio 2007-2021 | MDXG

MiMedx current ratio from 2007 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
MiMedx Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.15B $0.05B 2.92
2021-03-31 $0.15B $0.06B 2.71
2020-12-31 $0.16B $0.06B 2.72
2020-09-30 $0.17B $0.06B 2.99
2020-06-30 $0.11B $0.06B 1.69
2020-03-31 $0.12B $0.06B 1.82
2019-12-31 $0.12B $0.07B 1.83
2019-09-30 $0.13B $0.07B 1.83
2019-06-30 $0.12B $0.08B 1.57
2019-03-31 $0.06B $0.06B 0.89
2018-12-31 $0.07B $0.07B 1.04
2018-09-30 $0.00B 0.00
2018-06-30 $0.00B 0.00
2018-03-31 $0.00B 0.00
2017-12-31 $0.05B $0.05B 1.06
2017-09-30 $0.11B $0.04B 3.25
2017-06-30 $0.13B $0.05B 2.57
2017-03-31 $0.12B $0.05B 2.46
2016-12-31 $0.13B $0.05B 2.49
2016-09-30 $0.11B $0.04B 2.56
2016-06-30 $0.10B $0.04B 2.64
2016-03-31 $0.10B $0.03B 3.30
2015-12-31 $0.10B $0.03B 3.60
2015-09-30 $0.10B $0.02B 4.22
2015-06-30 $0.09B $0.02B 4.72
2015-03-31 $0.08B $0.02B 4.46
2014-12-31 $0.09B $0.02B 4.66
2014-09-30 $0.08B $0.01B 5.35
2014-06-30 $0.07B $0.01B 6.69
2014-03-31 $0.07B $0.01B 7.08
2013-12-31 $0.07B $0.01B 6.81
2013-09-30 $0.03B $0.01B 3.10
2013-06-30 $0.02B $0.01B 3.51
2013-03-31 $0.02B $0.01B 3.47
2012-12-31 $0.02B $0.01B 3.61
2012-09-30 $0.02B $0.01B 1.53
2012-06-30 $0.01B $0.01B 0.95
2012-03-31 $0.01B $0.01B 1.04
2011-12-31 $0.01B $0.01B 1.45
2011-09-30 $0.00B $0.01B 0.44
2011-06-30 $0.00B $0.01B 0.65
2011-03-31 $0.00B $0.00B 0.87
2010-12-31 $0.00B $0.00B 1.36
2010-09-30 $0.00B $0.00B 0.81
2010-06-30 $0.00B $0.00B 2.64
2010-03-31 $0.00B $0.00B 2.14
2009-12-31 $0.00B $0.00B 4.46
2009-09-30 $0.00B $0.00B 0.10
2009-06-30 $0.00B $0.00B 1.51
2009-03-31 $0.00B $0.00B 0.07
2008-12-31 $0.00B $0.00B 0.73
2008-09-30 $0.00B $0.00B 1.57
2008-06-30 $0.00B $0.00B 4.68
2008-03-31 $0.01B $0.00B 7.32
2007-12-31 $0.00B 0.00
2007-09-30 $0.00B $0.00B 0.08
2007-06-30 $0.00B $0.00B 0.56
2007-03-31 $0.00B $0.00B 0.65
2006-12-31 $0.01B $0.00B 6.52
2006-09-30 $0.00B 0.00
2006-06-30 $0.00B 0.00
2006-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.787B $0.248B
MiMedx is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. `Innovations in Regenerative Biomaterials` is the framework behind their mission to give physicians products and tissues to help the body heal itself. Their biomaterial platform technologies include AmnioFix and EpiFix, their tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through their donor program, a mother delivering via full-term Caesarean section birth can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. They process the human amniotic membrane utilizing their proprietary PURION Process, to produce a safe and effective implant.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76